Denosumab for bone metastases.
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary; D002118:Calcium / Q000378:metabolism; D000069448:Denosumab; D006801:Humans; D009369:Neoplasms / Q000473:pathology; D010010:Osteoclasts / Q000187:drug effects / Q000378:metabolism; D053245:RANK Ligand / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053245:RANK Ligand; D000069448:Denosumab; D002118:Calcium